Mizuho Securities Reiterates Neutral Rating on Pfizer (PFE), Seeks More Clearance on Longer-Term Outlook
Tweet Send to a Friend
Mizuho Securities analyst Vamil Divan reiterated a Neutral rating and $55.00 price target on Pfizer (NYSE: PFE), following the company's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
